Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Storage and voiding symptoms: pathophysiologic aspects.

Karl Erik Andersson1

  • 1Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden. Karl-Erik.Andersson@klinfarm.lu.se

Urology
|December 10, 2003
PubMed
Summary

Lower urinary tract symptoms (LUTS) involve storage, voiding, and postmicturition issues. Multiple mechanisms, including receptor involvement and structural changes, contribute to LUTS, explaining varied treatment responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the Site and Mechanism of Action of β<sub>3</sub>-Adrenoceptor Agonists in the Bladder.

International neurourology journal·2017
Same author

Fundamentals and clinical perspective of urethral sphincter instability as a contributing factor in patients with lower urinary tract dysfunction--ICI-RS 2014.

Neurourology and urodynamics·2016
Same author

Superoxide overproduction and kidney fibrosis: a new animal model.

Einstein (Sao Paulo, Brazil)·2015
Same author

Pelvic floor disorders: linking genetic risk factors to biochemical changes.

BJU international·2011
Same author

Effects of tramadol on rat detrusor overactivity induced by experimental cerebral infarction.

European urology·2003
Same author

Overview consensus statement.

Urology·2002

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Lower urinary tract symptoms (LUTS) are complex, affecting both men and women.
  • While often linked to benign prostatic hyperplasia (BPH), LUTS pathogenesis involves multiple factors beyond prostatic enlargement.
  • The role of alpha-adrenoceptors (ARs) and other receptors in LUTS is under investigation.

Purpose of the Study:

  • To explore the diverse pathophysiologic mechanisms underlying lower urinary tract symptoms (LUTS).
  • To investigate the potential roles of various receptors and structural changes in LUTS development.
  • To understand the basis for individual variations in LUTS treatment response.

Main Methods:

  • Review of existing literature on LUTS, benign prostatic hyperplasia (BPH), and receptor pharmacology.
  • Analysis of studies investigating alpha-ARs, beta-ARs, muscarinic receptors, and purinergic receptors in the context of LUTS.
  • Examination of structural bladder changes and their correlation with detrusor overactivity and LUTS.

Main Results:

  • Evidence suggests LUTS involve complex interactions, not solely outflow obstruction.
  • Upregulation of contraction-mediating alpha-ARs and downregulation of relaxation-mediating beta-ARs are hypothesized but not consistently confirmed in human bladder tissue.
  • Muscarinic and purinergic receptors are implicated in LUTS pathogenesis.
  • Structural bladder changes like smooth muscle hypertrophy are common in BPH patients with LUTS, but their causal link to obstruction is unclear.
  • Central nervous system factors may also contribute to persistent overactive voiding.

Conclusions:

  • LUTS result from a combination of overlapping pathophysiologic mechanisms.
  • Understanding these diverse mechanisms is crucial for explaining individual differences in treatment efficacy for LUTS.
  • Further research is needed to fully elucidate the roles of different receptors and central nervous system involvement in LUTS.

Related Experiment Videos